277 related articles for article (PubMed ID: 30096649)
21. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
Worek F; Thiermann H
Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
[TBL] [Abstract][Full Text] [Related]
22. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
Lo R; Ganguly B
Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
[TBL] [Abstract][Full Text] [Related]
23. New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin.
Hrabinova M; Musilek K; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2006 Oct; 21(5):515-9. PubMed ID: 17194020
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
25. New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics.
Mlakić M; Čadež T; Šinko G; Škorić I; Kovarik Z
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927082
[TBL] [Abstract][Full Text] [Related]
26. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374
[TBL] [Abstract][Full Text] [Related]
27. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking.
Musilek K; Komloova M; Holas O; Horova A; Pohanka M; Gunn-Moore F; Dohnal V; Dolezal M; Kuca K
Bioorg Med Chem; 2011 Jan; 19(2):754-62. PubMed ID: 21215642
[TBL] [Abstract][Full Text] [Related]
28. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship for the reactivators of acetylcholinesterase inhibited by nerve agent VX.
Kuca K; Musilek K; Jun D; Karasova J; Soukup O; Pejchal J; Hrabinova M
Med Chem; 2013 Aug; 9(5):689-93. PubMed ID: 22779796
[TBL] [Abstract][Full Text] [Related]
30. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
31. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
32. Y124 at the peripheral anionic site is important for the reactivation of nerve agent-inhibited acetylcholinesterase by H oximes.
Luo C; Chambers C; Pattabiraman N; Tong M; Tipparaju P; Saxena A
Biochem Pharmacol; 2010 Nov; 80(9):1427-36. PubMed ID: 20655881
[TBL] [Abstract][Full Text] [Related]
33. Conjugates of salicylaldoximes and peripheral site ligands: Novel efficient nonquaternary reactivators for nerve agent-inhibited acetylcholinesterase.
Wei Z; Liu YQ; Wang SZ; Yao L; Nie HF; Wang YA; Liu XY; Zheng ZB; Li S
Bioorg Med Chem; 2017 Aug; 25(16):4497-4505. PubMed ID: 28684009
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
[TBL] [Abstract][Full Text] [Related]
35. Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents.
Zorbaz T; Malinak D; Hofmanova T; Maraković N; Žunec S; Hrvat NM; Andrys R; Psotka M; Zandona A; Svobodova J; Prchal L; Fingler S; Katalinić M; Kovarik Z; Musilek K
Eur J Med Chem; 2022 Aug; 238():114377. PubMed ID: 35526478
[TBL] [Abstract][Full Text] [Related]
36. Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.
Gerlits O; Kong X; Cheng X; Wymore T; Blumenthal DK; Taylor P; Radić Z; Kovalevsky A
J Biol Chem; 2019 Jul; 294(27):10607-10618. PubMed ID: 31138650
[TBL] [Abstract][Full Text] [Related]
37. Discovery of non-oxime reactivators using an in silico pharmacophore model of oxime reactivators of OP-inhibited acetylcholinesterase.
Bhattacharjee AK; Marek E; Le HT; Gordon RK
Eur J Med Chem; 2012 Mar; 49():229-38. PubMed ID: 22309910
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of small organic molecule as reactivator of organophosphorus inhibited acetylcholinesterase.
Thakur A; Patwa J; Pant S; Jeet Singh Flora S; Sharma A
Drug Chem Toxicol; 2024 Jan; 47(1):26-41. PubMed ID: 36514993
[TBL] [Abstract][Full Text] [Related]
39. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity.
Artursson E; Andersson PO; Akfur C; Linusson A; Börjegren S; Ekström F
Biochem Pharmacol; 2013 May; 85(9):1389-97. PubMed ID: 23376121
[TBL] [Abstract][Full Text] [Related]
40. Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase.
Franjesevic AJ; Sillart SB; Beck JM; Vyas S; Callam CS; Hadad CM
Chemistry; 2019 Apr; 25(21):5337-5371. PubMed ID: 30444932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
